Repligen Corp (NASDAQ: RGEN) reported Q1 EPS of $0.09, $0.03 better than the analyst estimate of $0.06. Revenue for the quarter came in at $15.6 million versus the consensus estimate of $14.9 million.

Repligen Corp sees FY2014 revenue of $59 - $62 million, versus prior guidance of $58 - $61 million and the consensus of $59 million.

For earnings history and earnings-related data on Repligen Corp (RGEN) click here.